更多...
收起
This gene encodes a nuclear-localized E3 ubiquitin ligase. The encoded protein can promote tumor formation by targeting tumor suppressor proteins, such as p53, for proteasomal degradation. This gene is itself transcriptionally-regulated by p53. Overexpression or amplification of this locus is detected in a variety of different cancers. There is a pseudogene for this gene on chromosome 2. Alternative splicing results in a multitude of transcript variants, many of which may be expressed only in tumor cells. [provided by RefSeq, Jun 2013]
[中文简述(自动翻译):]  该基因编码一个核本地化的E3泛素连接酶。所编码的蛋白质可通过靶向肿瘤抑制蛋白,如p53,对蛋白酶体降解促进肿瘤的形成。该基因是由p53基因本身转录上调。过表达或该基因座的扩增在各种不同的癌症的检测。有这个基因在染色体2.选择性剪接的结果在转录变异体,其中有许多可能只在肿瘤细胞中表达的大量假基因。 [由RefSeq的,2013年6月提供]
MDM2基因(以及对应的蛋白质)的细胞分布位置:
MDM2基因的本体(GO)信息:
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Mammary Neoplasms | 0.247956418 | 24 | 2 | BeFree_CTD_human_GAD_LHGDN_RGD |
| Li-Fraumeni Syndrome | 0.133897074 | 15 | 2 | BeFree_GAD_LHGDN_ORPHANET |
| melanoma | 0.13198705 | 19 | 3 | BeFree_CTD_human_GAD |
| Prostatic Neoplasms | 0.128001298 | 6 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Liposarcoma, Dedifferentiated | 0.127600372 | 28 | 0 | BeFree_ORPHANET |
| Non-Small Cell Lung Carcinoma | 0.126514605 | 25 | 0 | BeFree_CTD_human |
| Liposarcoma, well differentiated | 0.125157396 | 19 | 0 | BeFree_ORPHANET |
| Neoplastic Cell Transformation | 0.122367032 | 2 | 0 | CTD_human_GAD |
| HIV Infections | 0.120814326 | 4 | 0 | BeFree_CTD_human |
| Precancerous Conditions | 0.120542884 | 3 | 0 | BeFree_CTD_human |
| Male infertility | 0.120271442 | 1 | 0 | BeFree_CTD_human |
| Peripheral Neuropathy | 0.12 | 1 | 0 | CTD_human |
| ACCELERATED TUMOR FORMATION, SUSCEPTIBILITY TO | 0.12 | 0 | 1 | CLINVAR |
| Transient Ischemic Attack | 0.08 | 1 | 0 | RGD |
| Diabetes Mellitus, Experimental | 0.08 | 1 | 0 | RGD |
| Fetal Growth Retardation | 0.08 | 1 | 0 | RGD |
| Hypothermia, natural | 0.08 | 1 | 0 | RGD |
| Ichthyoses | 0.08 | 1 | 0 | RGD |
| Intermittent Claudication | 0.08 | 1 | 0 | RGD |
| Liver diseases | 0.08 | 1 | 0 | RGD |
| Myocardial Reperfusion Injury | 0.08 | 1 | 0 | RGD |
| Pancreatitis | 0.08 | 1 | 0 | RGD |
| Priapism | 0.08 | 1 | 0 | RGD |
| Post-Traumatic Stress Disorder | 0.08 | 1 | 0 | RGD |
| Malignant neoplasm of breast | 0.05931642 | 83 | 7 | BeFree_GAD |
| Malignant neoplasm of lung | 0.042291526 | 29 | 0 | BeFree_GAD |
| Sarcoma | 0.038322962 | 93 | 2 | BeFree_LHGDN |
| Carcinogenesis | 0.035287443 | 130 | 1 | BeFree |
| Lung Neoplasms | 0.030338984 | 15 | 0 | BeFree_GAD_LHGDN |
| Squamous cell carcinoma | 0.030332933 | 34 | 2 | BeFree_GAD_LHGDN |
| liposarcoma | 0.024207984 | 43 | 0 | BeFree_LHGDN |
| Liver carcinoma | 0.021507378 | 33 | 2 | BeFree_GAD_LHGDN |
| Glioblastoma | 0.021235936 | 33 | 0 | BeFree_GAD_LHGDN |
| Breast Carcinoma | 0.020901024 | 77 | 7 | BeFree |
| Chronic Lymphocytic Leukemia | 0.019445464 | 19 | 2 | BeFree_GAD_LHGDN |
| Malignant neoplasm of prostate | 0.018154268 | 34 | 0 | BeFree_GAD |
| Malignant neoplasm of urinary bladder | 0.017730936 | 15 | 0 | BeFree_GAD |
| Colorectal Cancer | 0.017263997 | 22 | 2 | BeFree_GAD |
| Neuroblastoma | 0.016254175 | 25 | 0 | BeFree_GAD |
| Glioma | 0.01596892 | 22 | 2 | BeFree_GAD_LHGDN |
| Colorectal Neoplasms | 0.015902907 | 6 | 0 | BeFree_GAD_LHGDN |
| Neoplasm Metastasis | 0.015144663 | 30 | 0 | BeFree_GAD_LHGDN |
| Bladder Neoplasm | 0.014078759 | 7 | 0 | BeFree_GAD_LHGDN |
| Rhabdomyosarcoma | 0.012516121 | 17 | 0 | BeFree_LHGDN |
| Brain Neoplasms | 0.012378044 | 6 | 0 | BeFree_GAD |
| Renal Cell Carcinoma | 0.012158802 | 17 | 0 | BeFree_GAD_LHGDN |
| Osteosarcoma | 0.012138939 | 36 | 3 | BeFree_GAD |
| leukemia | 0.011887361 | 17 | 0 | BeFree_GAD_LHGDN |
| Mouth Neoplasms | 0.01183516 | 5 | 0 | GAD |
| Leukemia, Myelocytic, Acute | 0.011791553 | 27 | 1 | BeFree_GAD |
| Endometrial Neoplasms | 0.010182764 | 3 | 0 | GAD_LHGDN |
| Adenocarcinoma | 0.009901391 | 11 | 3 | BeFree_GAD_LHGDN |
| Skin Neoplasms | 0.009468128 | 4 | 0 | GAD |
| Papillomavirus Infections | 0.009468128 | 4 | 0 | GAD |
| Lymphoma | 0.009434452 | 18 | 0 | BeFree_GAD_LHGDN |
| Prostate carcinoma | 0.008143256 | 30 | 0 | BeFree |
| Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.008077243 | 12 | 0 | BeFree_GAD_LHGDN |
| Pancreatic Neoplasm | 0.008001298 | 4 | 0 | BeFree_GAD_LHGDN |
| Liver neoplasms | 0.007915422 | 6 | 0 | BeFree_GAD |
| Tumor Progression | 0.007871814 | 29 | 0 | BeFree |
| Malignant neoplasm of stomach | 0.007795869 | 21 | 4 | BeFree_GAD |
| Retinoblastoma | 0.007795869 | 20 | 0 | BeFree_GAD |
| Stomach Neoplasms | 0.007729856 | 3 | 0 | BeFree_GAD_LHGDN |
| Uterine Cervical Neoplasm | 0.007101096 | 3 | 0 | GAD |
| Malignant neoplasm of ovary | 0.006981544 | 17 | 1 | BeFree_GAD |
| Carcinoma of lung | 0.006514605 | 24 | 0 | BeFree |
| Central neuroblastoma | 0.006514605 | 24 | 0 | BeFree |
| Endometrial Carcinoma | 0.00643866 | 15 | 3 | BeFree_GAD |
| Osteosarcoma of bone | 0.006243163 | 23 | 2 | BeFree |
| Carcinoma, Transitional Cell | 0.00617715 | 5 | 0 | BeFree_GAD_LHGDN |
| B-Cell Lymphomas | 0.00617715 | 6 | 0 | BeFree_GAD_LHGDN |
| Malignant neoplasm of esophagus | 0.006091273 | 6 | 0 | BeFree_GAD |
| Hodgkin Disease | 0.005991584 | 4 | 0 | BeFree_LHGDN |
| Thyroid Neoplasm | 0.005720142 | 3 | 0 | BeFree_LHGDN |
| Colorectal Carcinoma | 0.005700279 | 21 | 2 | BeFree |
| Stomach Carcinoma | 0.005700279 | 21 | 4 | BeFree |
| Rheumatoid Arthritis | 0.005634266 | 3 | 1 | BeFree_GAD_LHGDN |
| Myeloid Leukemia | 0.005276948 | 4 | 0 | BeFree_GAD |
| Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.004895885 | 9 | 0 | BeFree_LHGDN |
| Lipoma | 0.004885954 | 18 | 0 | BeFree |
| Ovarian Carcinoma | 0.004885954 | 18 | 1 | BeFree |
| Head and Neck Neoplasms | 0.004734064 | 2 | 0 | GAD |
| Lymphoma, Non-Hodgkin | 0.004734064 | 2 | 0 | GAD |
| Nasopharyngeal Neoplasms | 0.004734064 | 2 | 0 | GAD |
| leiomyosarcoma | 0.004624443 | 8 | 0 | BeFree_LHGDN |
| Mixed Salivary Gland Tumor | 0.003810118 | 4 | 0 | BeFree_LHGDN |
| Malignant neoplasm of endometrium | 0.003800186 | 14 | 3 | BeFree |
| Carcinoma of bladder | 0.003800186 | 14 | 0 | BeFree |
| Atypical Lipoma | 0.003800186 | 14 | 0 | BeFree |
| Uterine Corpus Cancer | 0.003800186 | 14 | 3 | BeFree |
| Esophageal Neoplasms | 0.003724241 | 6 | 0 | BeFree_GAD |
| Diffuse Large B-Cell Lymphoma | 0.003724241 | 6 | 0 | BeFree_GAD |
| ovarian neoplasm | 0.003724241 | 6 | 0 | BeFree_GAD |
| Leukoplakia | 0.003452799 | 4 | 0 | BeFree_GAD |
| Meningioma | 0.003452799 | 5 | 0 | BeFree_GAD |
| Adenocarcinoma of pancreas | 0.003452799 | 4 | 0 | BeFree_GAD |
| Malignant neoplasm of liver | 0.003452799 | 5 | 0 | BeFree_GAD |
| Hepatitis C, Chronic | 0.003267234 | 2 | 0 | BeFree_LHGDN |
| Nasopharyngeal carcinoma | 0.003257302 | 12 | 7 | BeFree |
| Carcinosarcoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Colonic Neoplasms | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Epilepsy, Temporal Lobe | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| synovial sarcoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Rhabdomyosarcoma, Embryonal | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Verrucous carcinoma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Angiofibroma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Acute lymphocytic leukemia | 0.002985861 | 11 | 0 | BeFree |
| Pancreatic carcinoma | 0.002985861 | 11 | 0 | BeFree |
| Squamous cell carcinoma of esophagus | 0.002985861 | 11 | 1 | BeFree |
| Myeloid Leukemia, Chronic | 0.002909916 | 3 | 1 | BeFree_GAD |
| oligodendroglioma | 0.002909916 | 3 | 0 | BeFree_GAD |
| Cancer of Nasopharynx | 0.002909916 | 3 | 0 | BeFree_GAD |
| Hepatitis B, Chronic | 0.002909916 | 2 | 2 | BeFree_GAD |
| Epithelial ovarian cancer | 0.002909916 | 3 | 0 | BeFree_GAD |
| Cessation of life | 0.00272435 | 1 | 0 | LHGDN |
| Salivary Gland Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Infection | 0.00272435 | 1 | 0 | LHGDN |
| Malignant Fibrous Histiocytoma | 0.002714419 | 10 | 0 | BeFree |
| Malignant neoplasm of pancreas | 0.002714419 | 10 | 0 | BeFree |
| Crohn Disease | 0.002638474 | 1 | 0 | BeFree_GAD |
| Cervical Intraepithelial Neoplasia | 0.002638474 | 2 | 0 | BeFree_GAD |
| Sepsis | 0.002638474 | 1 | 0 | BeFree_GAD |
| Malignant tumor of colon | 0.002442977 | 9 | 0 | BeFree |
| Malignant tumor of cervix | 0.002442977 | 9 | 0 | BeFree |
| Leukemia, Lymphocytic, Acute, L1 | 0.002442977 | 9 | 2 | BeFree |
| Cervix carcinoma | 0.002442977 | 9 | 0 | BeFree |
| Colon Carcinoma | 0.002442977 | 9 | 0 | BeFree |
| Lipomatosis, Multiple | 0.002442977 | 9 | 0 | BeFree |
| Spontaneous abortion | 0.002367032 | 1 | 0 | GAD |
| Anoxia | 0.002367032 | 1 | 0 | GAD |
| Cocarcinogenesis | 0.002367032 | 1 | 0 | GAD |
| DNA Damage | 0.002367032 | 1 | 0 | GAD |
| Fibrosis | 0.002367032 | 1 | 0 | GAD |
| Hepatitis, Viral, Human | 0.002367032 | 1 | 0 | GAD |
| Kidney Neoplasm | 0.002367032 | 1 | 0 | GAD |
| Laryngeal neoplasm | 0.002367032 | 1 | 0 | GAD |
| Chronic Obstructive Airway Disease | 0.002367032 | 1 | 0 | GAD |
| Lymphatic Metastasis | 0.002367032 | 1 | 0 | GAD |
| Animal Mammary Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Neoplasm Recurrence, Local | 0.002367032 | 1 | 0 | GAD |
| Acoustic Neuroma | 0.002367032 | 1 | 0 | GAD |
| Occupational Diseases | 0.002367032 | 1 | 0 | GAD |
| Pharyngeal Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Helicobacter Infections | 0.002367032 | 1 | 0 | GAD |
| Choroid Plexus Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Neoplasms, Second Primary | 0.002367032 | 1 | 0 | GAD |
| Malignant neoplasm of brain | 0.002367032 | 1 | 0 | GAD |
| Choroid Plexus Papilloma | 0.002367032 | 1 | 0 | GAD |
| Restenosis | 0.002367032 | 1 | 0 | GAD |
| Retinal Neoplasms | 0.002367032 | 1 | 0 | GAD |
| Pregnancy loss | 0.002367032 | 1 | 0 | GAD |
| Carcinoma, Pancreatic Ductal | 0.002367032 | 1 | 0 | GAD |
| Granulomatosis with polyangiitis | 0.002367032 | 1 | 0 | GAD |
| Multiple Myeloma | 0.002171535 | 8 | 0 | BeFree |
| Soft Tissue Neoplasms | 0.002171535 | 8 | 0 | BeFree |
| Leukemogenesis | 0.002171535 | 8 | 0 | BeFree |
| Glioblastoma Multiforme | 0.002171535 | 8 | 0 | BeFree |
| Ichthyosis, X-Linked | 0.001900093 | 7 | 0 | BeFree |
| Esophageal carcinoma | 0.001900093 | 7 | 0 | BeFree |
| Medulloblastoma | 0.001628651 | 6 | 0 | BeFree |
| Liposarcoma, Pleomorphic | 0.001628651 | 6 | 0 | BeFree |
| Germ cell tumor | 0.001628651 | 6 | 0 | BeFree |
| Lip and Oral Cavity Carcinoma | 0.001628651 | 6 | 5 | BeFree |
| Solid tumour | 0.001628651 | 6 | 0 | BeFree |
| Malignant Glioma | 0.001628651 | 6 | 0 | BeFree |
| Secondary malignant neoplasm of lymph node | 0.001628651 | 6 | 0 | BeFree |
| Bone neoplasms | 0.001357209 | 5 | 6 | BeFree |
| Kidney Failure, Acute | 0.001357209 | 5 | 0 | BeFree |
| Malignant neoplasm of mouth | 0.001357209 | 5 | 5 | BeFree |
| Acute respiratory failure | 0.001357209 | 5 | 0 | BeFree |
| Squamous cell carcinoma of the head and neck | 0.001357209 | 5 | 0 | BeFree |
| Ataxia Telangiectasia | 0.001085767 | 4 | 0 | BeFree |
| Choriocarcinoma | 0.001085767 | 4 | 0 | BeFree |
| Hemangiosarcoma | 0.001085767 | 4 | 0 | BeFree |
| Hepatitis B | 0.001085767 | 4 | 2 | BeFree |
| Liver Cirrhosis | 0.001085767 | 4 | 0 | BeFree |
| Cutaneous Melanoma | 0.001085767 | 4 | 2 | BeFree |
| Adenocarcinoma of lung (disorder) | 0.001085767 | 4 | 0 | BeFree |
| childhood rhabdomyosarcoma | 0.001085767 | 4 | 0 | BeFree |
| Gastrointestinal Stromal Tumors | 0.001085767 | 4 | 0 | BeFree |
| Adenocarcinoma Of Esophagus | 0.001085767 | 4 | 2 | BeFree |
| Anaplastic astrocytoma | 0.001085767 | 4 | 0 | BeFree |
| Malignant neoplasm of kidney | 0.001085767 | 4 | 0 | BeFree |
| Malignant Peripheral Nerve Sheath Tumor | 0.001085767 | 4 | 0 | BeFree |
| Pancreatic Ductal Adenocarcinoma | 0.001085767 | 4 | 0 | BeFree |
| Renal carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Tumor Angiogenesis | 0.001085767 | 4 | 0 | BeFree |
| Ameloblastoma | 0.000814326 | 3 | 0 | BeFree |
| Anaplasia | 0.000814326 | 3 | 0 | BeFree |
| Astrocytoma | 0.000814326 | 3 | 0 | BeFree |
| Blast Phase | 0.000814326 | 3 | 2 | BeFree |
| Burkitt Lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Bronchogenic Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Chondrosarcoma | 0.000814326 | 3 | 0 | BeFree |
| Fibroid Tumor | 0.000814326 | 3 | 0 | BeFree |
| Mesothelioma | 0.000814326 | 3 | 0 | BeFree |
| Uterine Fibroids | 0.000814326 | 3 | 0 | BeFree |
| Virus Diseases | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of testis | 0.000814326 | 3 | 0 | BeFree |
| Pleomorphic Lipoma | 0.000814326 | 3 | 0 | BeFree |
| Lipomatous neoplasm | 0.000814326 | 3 | 0 | BeFree |
| Embryonal Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Cancer of Head and Neck | 0.000814326 | 3 | 0 | BeFree |
| Liver and Intrahepatic Biliary Tract Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Carcinoma ex pleomorphic adenoma | 0.000814326 | 3 | 0 | BeFree |
| Intrahepatic Cholangiocarcinoma | 0.000814326 | 3 | 0 | BeFree |
| Malignant mesothelioma | 0.000814326 | 3 | 0 | BeFree |
| Breast Cancer, Familial | 0.000814326 | 3 | 0 | BeFree |
| Skin carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Malignant Pleural Mesothelioma | 0.000814326 | 3 | 0 | BeFree |
| Helicobacter pylori infection | 0.000814326 | 3 | 0 | BeFree |
| Intimal sarcoma | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of skin | 0.000542884 | 2 | 0 | BeFree |
| Mucinous Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
| Carcinoma, Papillary | 0.000542884 | 2 | 0 | BeFree |
| Congenital chromosomal disease | 0.000542884 | 2 | 0 | BeFree |
| Ulcerative Colitis | 0.000542884 | 2 | 0 | BeFree |
| Phyllodes Tumor | 0.000542884 | 2 | 0 | BeFree |
| Ependymoma | 0.000542884 | 2 | 0 | BeFree |
| Giant Cell Tumors | 0.000542884 | 2 | 0 | BeFree |
| Adult T-Cell Lymphoma/Leukemia | 0.000542884 | 2 | 0 | BeFree |
| Leukopenia | 0.000542884 | 2 | 3 | BeFree |
| Neurofibromatosis 2 | 0.000542884 | 2 | 0 | BeFree |
| Neutropenia | 0.000542884 | 2 | 3 | BeFree |
| Odontogenic Tumors | 0.000542884 | 2 | 0 | BeFree |
| Polycythemia Vera | 0.000542884 | 2 | 0 | BeFree |
| Seizures | 0.000542884 | 2 | 0 | BeFree |
| Benign Neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of nasopharynx | 0.000542884 | 2 | 0 | BeFree |
| Secondary malignant neoplasm of lung | 0.000542884 | 2 | 0 | BeFree |
| Cholangiocarcinoma | 0.000542884 | 2 | 0 | BeFree |
| Adult Acute Myeloblastic Leukemia | 0.000542884 | 2 | 0 | BeFree |
| pediatric acute myeloblastic leukemia | 0.000542884 | 2 | 0 | BeFree |
| Uveal melanoma | 0.000542884 | 2 | 0 | BeFree |
| Medullary carcinoma of thyroid | 0.000542884 | 2 | 0 | BeFree |
| Disseminated neuroblastoma | 0.000542884 | 2 | 0 | BeFree |
| Laryngeal Squamous Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Tumor necrosis | 0.000542884 | 2 | 0 | BeFree |
| Adenoameloblastoma | 0.000542884 | 2 | 0 | BeFree |
| Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000542884 | 2 | 0 | BeFree |
| Nijmegen Breakage Syndrome | 0.000542884 | 2 | 0 | BeFree |
| Trisomy 12 | 0.000542884 | 2 | 0 | BeFree |
| Thyroid carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Ewings sarcoma | 0.000542884 | 2 | 0 | BeFree |
| Carcinoma of larynx | 0.000542884 | 2 | 0 | BeFree |
| Well Differentiated Oligodendroglioma | 0.000542884 | 2 | 0 | BeFree |
| Familial Retinoblastoma | 0.000542884 | 2 | 0 | BeFree |
| Malignant Squamous Cell Neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Invasive breast carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Testicular malignant germ cell tumor | 0.000542884 | 2 | 0 | BeFree |
| Invasive Ductal Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Childhood Leukemia | 0.000542884 | 2 | 0 | BeFree |
| Hereditary Malignant Neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Hepatitis B Virus-Related Hepatocellular Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Hepatocarcinogenesis | 0.000542884 | 2 | 0 | BeFree |
| Cancer Cell Growth | 0.000542884 | 2 | 0 | BeFree |
| Tumor Promotion | 0.000542884 | 2 | 0 | BeFree |
| Xenograft Model | 0.000542884 | 2 | 0 | BeFree |
| Cirrhosis | 0.000542884 | 2 | 0 | BeFree |
| Meningioma, benign, no ICD-O subtype | 0.000542884 | 2 | 0 | BeFree |
| Experimental Organism Basal Cell Carcinoma | 0.000542884 | 2 | 2 | BeFree |
| Abdominal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Adenovirus Infections | 0.000271442 | 1 | 0 | BeFree |
| Arteriosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Congenital arteriovenous malformation | 0.000271442 | 1 | 0 | BeFree |
| Atherosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Tooth Attrition | 0.000271442 | 1 | 0 | BeFree |
| Autoimmune Diseases | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of larynx | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of thyroid | 0.000271442 | 1 | 0 | BeFree |
| Adenoid Cystic Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Mental Depression | 0.000271442 | 1 | 0 | BeFree |
| Depressive disorder | 0.000271442 | 1 | 0 | BeFree |
| Breast Fibrocystic Disease | 0.000271442 | 1 | 0 | BeFree |
| Fibrosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Gastritis, Atrophic | 0.000271442 | 1 | 0 | BeFree |
| Gastroesophageal reflux disease | 0.000271442 | 1 | 2 | BeFree |
| Hamartoma | 0.000271442 | 1 | 0 | BeFree |
| hemangiopericytoma | 0.000271442 | 1 | 0 | BeFree |
| Hemochromatosis | 0.000271442 | 1 | 0 | BeFree |
| Pulmonary Hypertension | 0.000271442 | 1 | 0 | BeFree |
| Leukemia, Plasma Cell | 0.000271442 | 1 | 0 | BeFree |
| Liver Cirrhosis, Alcoholic | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma, Follicular | 0.000271442 | 1 | 0 | BeFree |
| Lymphoproliferative Disorders | 0.000271442 | 1 | 0 | BeFree |
| Myoepithelioma | 0.000271442 | 1 | 0 | BeFree |
| Neoplasms, Connective Tissue | 0.000271442 | 1 | 0 | BeFree |
| Neurilemmoma | 0.000271442 | 1 | 0 | BeFree |
| Nevus | 0.000271442 | 1 | 0 | BeFree |
| Melanocytic nevus | 0.000271442 | 1 | 0 | BeFree |
| Papilloma | 0.000271442 | 1 | 0 | BeFree |
| Parathyroid Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| polyps | 0.000271442 | 1 | 0 | BeFree |
| Retinal Detachment | 0.000271442 | 1 | 0 | BeFree |
| Kaposi Sarcoma | 0.000271442 | 1 | 0 | BeFree |
| Seminoma | 0.000271442 | 1 | 0 | BeFree |
| Sezary Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Synovitis | 0.000271442 | 1 | 0 | BeFree |
| Giant Cell Arteritis | 0.000271442 | 1 | 0 | BeFree |
| Thrombocythemia, Essential | 0.000271442 | 1 | 0 | BeFree |
| Vitiligo | 0.000271442 | 1 | 0 | BeFree |
| Common wart | 0.000271442 | 1 | 0 | BeFree |
| Xeroderma Pigmentosum | 0.000271442 | 1 | 0 | BeFree |
| Low Grade Lymphoma (neoplasm) | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma, T-Cell, Cutaneous | 0.000271442 | 1 | 0 | BeFree |
| Severe Combined Immunodeficiency | 0.000271442 | 1 | 0 | BeFree |
| Pancreatitis, Chronic | 0.000271442 | 1 | 0 | BeFree |
| Epstein-Barr Virus Infections | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of lung | 0.000271442 | 1 | 0 | BeFree |
| Oral Cavity Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of oropharynx | 0.000271442 | 1 | 0 | BeFree |
| Sarcoma, Spindle Cell | 0.000271442 | 1 | 0 | BeFree |
| Hepatoblastoma | 0.000271442 | 1 | 0 | BeFree |
| Mixed Tumor, Mullerian | 0.000271442 | 1 | 0 | BeFree |
| Liposarcoma, Myxoid | 0.000271442 | 1 | 0 | BeFree |
| Parosteal Osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma, Clear Cell | 0.000271442 | 1 | 0 | BeFree |
| Medullary carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Mucoepidermoid Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Neoplasms, Neuroepithelial | 0.000271442 | 1 | 0 | BeFree |
| Ganglioneuroblastoma | 0.000271442 | 1 | 0 | BeFree |
| gliosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Nerve Sheath Tumors | 0.000271442 | 1 | 0 | BeFree |
| adult soft tissue sarcoma | 0.000271442 | 1 | 0 | BeFree |
| Papillary thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Mucosa-Associated Lymphoid Tissue Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Proliferative vitreoretinopathy | 0.000271442 | 1 | 0 | BeFree |
| Multiple tumors | 0.000271442 | 1 | 3 | BeFree |
| Retractile Mesenteritis | 0.000271442 | 1 | 0 | BeFree |
| Disorder of lymph node | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma breast stage IV | 0.000271442 | 1 | 0 | BeFree |
| Metastatic osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
| recurrent childhood acute lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
| Medulloblastoma, Adult | 0.000271442 | 1 | 0 | BeFree |
| Metastatic melanoma | 0.000271442 | 1 | 0 | BeFree |
| stage, non-small cell lung cancer | 0.000271442 | 1 | 0 | BeFree |
| stage, ovarian epithelial cancer | 0.000271442 | 1 | 0 | BeFree |
| Leiomyosarcoma of uterus | 0.000271442 | 1 | 0 | BeFree |
| Inflammatory Myofibroblastic Tumor | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma, intestinal type | 0.000271442 | 1 | 0 | BeFree |
| Spindle cell lipoma | 0.000271442 | 1 | 0 | BeFree |
| Anaplastic Oligodendroglioma | 0.000271442 | 1 | 0 | BeFree |
| Human papilloma virus infection | 0.000271442 | 1 | 0 | BeFree |
| Benign tumor of salivary gland | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma of anal margin | 0.000271442 | 1 | 0 | BeFree |
| Hematologic Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Dermatofibrosarcoma Protuberans | 0.000271442 | 1 | 0 | BeFree |
| Secondary malignant neoplasm of liver | 0.000271442 | 1 | 0 | BeFree |
| Malignant tumor of eye | 0.000271442 | 1 | 0 | BeFree |
| Benign neurologic neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Chronic active hepatitis | 0.000271442 | 1 | 0 | BeFree |
| Sleep Apnea, Obstructive | 0.000271442 | 1 | 0 | BeFree |
| Granulomatosis | 0.000271442 | 1 | 0 | BeFree |
| Composite Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Progressive Neoplastic Disease | 0.000271442 | 1 | 0 | BeFree |
| Ewings sarcoma-primitive neuroectodermal tumor (PNET) | 0.000271442 | 1 | 0 | BeFree |
| Malignant fibrous histiocytoma of bone | 0.000271442 | 1 | 0 | BeFree |
| Febrile Neutropenia | 0.000271442 | 1 | 2 | BeFree |
| early pregnancy | 0.000271442 | 1 | 0 | BeFree |
| Arnold-Chiari Malformation, Type I | 0.000271442 | 1 | 0 | BeFree |
| Brain Tumor, Primary | 0.000271442 | 1 | 0 | BeFree |
| Localized Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Pancreatic carcinoma resectable | 0.000271442 | 1 | 0 | BeFree |
| Retinoblastoma unilateral | 0.000271442 | 1 | 0 | BeFree |
| Undifferentiated (Embryonal) Sarcoma | 0.000271442 | 1 | 0 | BeFree |
| Breast adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Advanced cancer | 0.000271442 | 1 | 0 | BeFree |
| precancerous lesions | 0.000271442 | 1 | 0 | BeFree |
| Salivary gland carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Endometrial adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Spindle cell rhabdomyosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Intratubular malignant germ cells | 0.000271442 | 1 | 0 | BeFree |
| Spindle cell liposarcoma | 0.000271442 | 1 | 0 | BeFree |
| Primary Effusion Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Precursor B-cell lymphoblastic leukemia | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma of large intestine | 0.000271442 | 1 | 0 | BeFree |
| Classical Hodgkin's Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Desmoplastic melanoma | 0.000271442 | 1 | 0 | BeFree |
| Gastric Cardia Adenocarcinoma | 0.000271442 | 1 | 2 | BeFree |
| Gastric Cardia Carcinoma | 0.000271442 | 1 | 2 | BeFree |
| Hereditary Nonpolyposis Colorectal Cancer | 0.000271442 | 1 | 0 | BeFree |
| Human Papillomavirus-Related Esophageal Squamous Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Inflammatory malignant fibrous histiocytoma | 0.000271442 | 1 | 0 | BeFree |
| Invasive Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Localized Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Oligodendroglial Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Treatment related acute myeloid leukaemia | 0.000271442 | 1 | 2 | BeFree |
| Differentiated Thyroid Gland Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Marginal Zone B-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Periosteal Osteosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Anal squamous cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Cardiomyopathy, Familial Idiopathic | 0.000271442 | 1 | 0 | BeFree |
| Benign melanocytic nevus | 0.000271442 | 1 | 0 | BeFree |
| Breast Cancer Model | 0.000271442 | 1 | 0 | BeFree |
| Mammary Tumorigenesis | 0.000271442 | 1 | 0 | BeFree |
| Poorly Differentiated Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
| Ganglioneuroblastoma, Nodular | 0.000271442 | 1 | 0 | BeFree |
| Malignant Conversion | 0.000271442 | 1 | 0 | BeFree |
| Salivary Gland Pleomorphic Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Rash and Dermatitis Adverse Event Associated with Chemoradiation | 0.000271442 | 1 | 0 | BeFree |
| tumor vasculature | 0.000271442 | 1 | 0 | BeFree |
| Enchondroma | 0.000271442 | 1 | 0 | BeFree |
| VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding) | 0.000271442 | 1 | 0 | BeFree |
| Urothelial Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Oropharyngeal Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Pancreatic carcinoma, familial | 0.000271442 | 1 | 0 | BeFree |
| Progressive cGVHD | 0.000271442 | 1 | 0 | BeFree |
| Triple Negative Breast Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Fibromyxosarcoma | 0.000271442 | 1 | 0 | BeFree |
忘记密码? 点击找回密码.
扫一扫右方二维码,关注微信订阅号,实时查看信息,关注医学生物学动态。